Skip to content

TECO®Fast Cryptococcus Antigen LFA 

Key Features


For early diagnosis of Cryptococcus infections such as Cryptococcus meningitis, and as a monitoring tool during therapy.

Product Description



Fast Cryptococcus neoformans Ag Lateral Flow Assay is used for the detection of cryptococcal capsular polysaccharide antigen in human serum/cerebral spinal fluid (CSF), offering a diagnostic reference for cryptococcal meningitis infection.


  • Fluorescence-based lateral flow assay designed for readout via reader.
  • Quantitative determination of the Cryptococcus antigen glycuronoxylomannan (GXM) in ng/mL in only 20 minutes.
  • Detects the respective serotypes A, B, C, D and AD.
  • Clinically validated for CSF and serum samples.
  • No sample treatment required.
  • Limit of detection: 0.1 ng/mL, clinical cut-off value: 0.5 ng/mL.

Request Quotation


Product
SKU
Pack Size
Qty
TECO®Fast Cryptococcus Antigen LFA
SKU
TE1085
Pack Size
50 tests

Request Documentation


TECO®Fast Cryptococcus Antigen LFA
TE1085

Latest News


The 2024 Emissions Report

As part of our commitment to sustainability, we partner with DHL to cut transport related emissions. Details available in our new 2024 Emissions Report!

New Brand to reflect growth, innovation, and a unified vision to become a leading global Specialty Diagnostics company

We are happy to announce that Eurobio Scientific UK will undertake a brand update to align with the evolving structure of the Eurobio Scientific Group.

This new brand embodies the collective strengths of all our affiliates, combining expertise and resources to create synergies to enhance our product offerings.

Navigating ER+ HER2- Early Breast Cancer

November 19, 2024 - Join us for the first seminar in our new series!

“Navigating ER+ HER2- Early Breast Cancer”

The session “What's new for high-risk early breast cancer patients” will focus on CDK4/6 inhibitors in the adjuvant setting for high-risk breast cancer patients, featuring a real-life case discussion and insights into the potential role of gene expression tests, including prospective validation data in high- risk patients (UNIRAD).

New Distribution Partnership with UTAK for Toxicology Quality Control Solutions

Eurobio Scientific UK is thrilled to announce its new partnership with UTAK, an esteemed American company specialising in Toxicology quality control solutions.

Contact Us